Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06123156 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer

Study acronym: RECTIL
StatusRecruiting
PhasePhase 3
Started2025-09-25
View on ClinicalTrials.gov ↗

Amendment history

2026-05-07
notable
Study Status, Contacts/Locations v2
Recruitment opened
Trial sites expanded: 0 → 14 locations
Start dateestimated 2026-03→confirmed 2025-09-25
2026-02-17
minor
Study Status v1
Primary completion date2028-05→2030-02
Completion date2028-05→2030-02
Start date2024-06→2026-03
2023-11-03
minor
Original filing
This study aims to evaluate the efficacy of erectile rehabilitation with Sildenafil, in men treated with neoadjuvant proctectomy and radiotherapy for rectal cancer, in preventing long-term erectile dysfunction at 12 months post-operatively.
Trial Details
NCT Number NCT06123156
Lead Sponsor University Hospital, Rouen
Conditions Rectal Cancer
Enrollment 188 participants
Start Date 2025-09-25
Primary Completion 2030-02 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-05-12